Quick Overview: Dr. Bryant England, a rheumatologist at the University of Nebraska, discusses the This Tuesday Night Rheumatology webinar reviewed ACR and EULAR ... is the point where we're getting to be more sophisticated in the way that we

Ra Ild Treatment Update - Detailed Overview & Context

Dr. Bryant England, a rheumatologist at the University of Nebraska, discusses the This Tuesday Night Rheumatology webinar reviewed ACR and EULAR ... is the point where we're getting to be more sophisticated in the way that we Drs. MeiLan Han, Ella Kazerooni, Justin Oldham, and Elizabeth Belloli discuss the latest This is a recorded Presentation for Recent Dr. Richard Conway discusses Abstract 2251 at ACR22 Convergence. Abstract 2251: Reduction in

Dr. El Ramahi discusses abstract presented at the ACR21 annual meeting. Dr. Michael Putman (Milwaukee, WI) reviews his approach to screening for Dr. Bryant England, Lincoln, NE, discusses The 2026 ERS/EULAR Guideline on Connective Tissue Disease–Associated Dr. Richard Conway, a rheumatologist in Dublin, discusses a case about managing progressive Web conférence des Jeudis de la Filière du 7 avril 2022 Screening for

Photo Gallery

Updates on Current Treatment Options for RA ILD
RA ILD treatment update
What is RA-ILD? Rheumatoid Arthritis Associated Interstitial Lung Disease #ild #pulmonaryfibrosis
ACR/CHEST Clinical Practice Guidelines on Treatment of ILD Systemic Autoimmune Rheumatic Diseases
Future Treatment of ILD
The Future of Treatment of RA-ILD: Dr. David Liew
Updates in the Diagnosis and Treatment of Interstitial Lung Disease
Rheumatoid Arthritis ILD - Recent changes and update 2024
Learn the signs of RA lung disease
ILD Guideline Caveats and Concerns
Tofacitinib and RA-ILD
Predictors of mortality in RA lung disease? Dr. Meral El Ramahi
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored